| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.50B | 7.69B | 5.98B | 5.90B | 6.80B |
| Gross Profit | 746.38M | 757.01M | 660.26M | 569.52M | 646.56M |
| EBITDA | 172.74M | 236.06M | 236.74M | 177.89M | 261.41M |
| Net Income | -2.99M | 50.74M | 25.73M | -10.20M | 77.38M |
Balance Sheet | |||||
| Total Assets | 5.79B | 6.08B | 5.57B | 4.84B | 4.94B |
| Cash, Cash Equivalents and Short-Term Investments | 973.93M | 1.04B | 1.07B | 760.66M | 648.84M |
| Total Debt | 947.35M | 1.01B | 773.63M | 539.51M | 551.74M |
| Total Liabilities | 3.51B | 3.79B | 3.28B | 2.58B | 2.67B |
| Stockholders Equity | 2.05B | 2.08B | 2.11B | 2.09B | 2.12B |
Cash Flow | |||||
| Free Cash Flow | 42.97M | -60.99M | 85.46M | 133.28M | 139.43M |
| Operating Cash Flow | 135.18M | 42.15M | 198.56M | 204.76M | 252.55M |
| Investing Cash Flow | -89.78M | -347.86M | -112.53M | -74.17M | -116.33M |
| Financing Cash Flow | -132.71M | 279.23M | 224.27M | -11.52M | 96.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$1.69B | 3.78 | 16.17% | 12.15% | -3.66% | 4.32% | |
73 Outperform | HK$1.08B | 17.58 | 5.24% | 13.24% | -13.83% | 50.41% | |
66 Neutral | HK$37.08B | 4.13 | 11.37% | 6.69% | -5.48% | -4.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | HK$160.62M | -52.94 | -0.14% | 5.26% | -15.53% | -105.86% | |
49 Neutral | HK$666.22M | -0.27 | -118.41% | ― | -3.72% | 21.15% | |
46 Neutral | HK$236.55M | -1.17 | -6.00% | 7.35% | 13.50% | -106.11% |